{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:28:13Z","timestamp":1789536493390,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.vaccine.2016.08.035","type":"journal-article","created":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T21:28:21Z","timestamp":1471901301000},"page":"4763-4770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["The BCG\u0394BCG1419c strain, which produces more pellicle in vitro, improves control of chronic tuberculosis in vivo"],"prefix":"10.1016","volume":"34","author":[{"given":"C\u00e9sar","family":"Pedroza-Rold\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Guapillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Barrios-Pay\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dulce","family":"Mata-Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel de Jes\u00fas","family":"Aceves-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Marquina-Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogelio","family":"Hern\u00e1ndez-Pando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Alberto","family":"Flores-Valdez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.08.035_b0005","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1016\/j.vaccine.2015.08.084","article-title":"Protection by novel vaccine candidates, Mycobacterium tuberculosis DeltamosR and DeltaechA7, against challenge with a Mycobacterium tuberculosis Beijing strain","volume":"33","author":"Marcus","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.035_b0010","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1016\/j.vaccine.2015.08.033","article-title":"Prospects in Mycobacterium bovis Bacille Calmette et Guerin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?","volume":"33","author":"Moliva","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.035_b0015","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1080\/21645515.2015.1040955","article-title":"Tuberculosis vaccine development: shifting focus amid increasing development challenges","volume":"11","author":"Graves","year":"2015","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2016.08.035_b0020","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1586\/14760584.2015.1089175","article-title":"Current efforts and future prospects in the development of live mycobacteria as vaccines","volume":"14","author":"Ng","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2016.08.035_b0025","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1016\/j.vaccine.2009.05.048","article-title":"Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis","volume":"27","author":"Sun","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.035_b0030","doi-asserted-by":"crossref","first-page":"e5590","DOI":"10.1371\/journal.pone.0005590","article-title":"Identification of T-cell antigens specific for latent Mycobacterium tuberculosis infection","volume":"4","author":"Schuck","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.08.035_b0035","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1016\/j.vaccine.2013.07.051","article-title":"Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials","volume":"31","author":"Arbues","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.035_b0040","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3389\/fmicb.2015.00658","article-title":"Antibiotic resistance in the opportunistic pathogen Stenotrophomonas maltophilia","volume":"6","author":"Sanchez","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2016.08.035_b0045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fmicb.2016.00014","article-title":"Vaccines directed against microorganisms or their products present during biofilm lifestyle: can we make a translation as a broad biological model to tuberculosis?","volume":"7","author":"Flores-Valdez","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2016.08.035_b0050","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev.micro.61.080706.093426","article-title":"Roles of cyclic diguanylate in the regulation of bacterial pathogenesis","volume":"61","author":"Tamayo","year":"2007","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.vaccine.2016.08.035_b0055","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/iub.1353","article-title":"The cyclic Di-GMP phosphodiesterase gene Rv1357c\/BCG1419c affects BCG pellicle production and in vivo maintenance","volume":"67","author":"Flores-Valdez","year":"2015","journal-title":"IUBMB Life"},{"key":"10.1016\/j.vaccine.2016.08.035_b0060","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1128\/IAI.74.3.1718-1724.2006","article-title":"Mycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB\/c model of progressive pulmonary tuberculosis","volume":"74","author":"Castillo-Rodal","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.08.035_b0065","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1365-2249.2002.01832.x","article-title":"Immunological and pathological comparative analysis between experimental latent tuberculous infection and progressive pulmonary tuberculosis","volume":"128","author":"Arriaga","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2016.08.035_b0070","doi-asserted-by":"crossref","first-page":"e47723","DOI":"10.1371\/journal.pone.0047723","article-title":"Animal welfare in studies on murine tuberculosis: assessing progress over a 12-year period and the need for further improvement","volume":"7","author":"Franco","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.08.035_b0075","doi-asserted-by":"crossref","first-page":"e1002399","DOI":"10.1371\/journal.ppat.1002399","article-title":"How \u201chumane\u201d is your endpoint? Refining the science-driven approach for termination of animal studies of chronic infection","volume":"8","author":"Franco","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2016.08.035_b0080","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1128\/IAI.00023-10","article-title":"Immunogenicity and protection induced by a Mycobacterium tuberculosis sigE mutant in a BALB\/c mouse model of progressive pulmonary tuberculosis","volume":"78","author":"Hernandez Pando","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.08.035_b0085","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1128\/IAI.57.6.1719-1724.1989","article-title":"Mechanisms of recrudescence of Mycobacterium bovis BCG infection in mice","volume":"57","author":"Cox","year":"1989","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.08.035_b0090","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.2741\/1291","article-title":"Persistent and dormant tubercle bacilli and latent tuberculosis","volume":"9","author":"Zhang","year":"2004","journal-title":"Front Biosci: J Virtual Lib"},{"key":"10.1016\/j.vaccine.2016.08.035_b0095","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1084\/jem.192.3.347","article-title":"Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2","volume":"192","author":"Scanga","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2016.08.035_b0100","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1002\/1521-4141(200012)30:12<3689::AID-IMMU3689>3.0.CO;2-4","article-title":"Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells","volume":"30","author":"van Pinxteren","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2016.08.035_b0105","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/mi.2011.14","article-title":"Macrophages and control of granulomatous inflammation in tuberculosis","volume":"4","author":"Flynn","year":"2011","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2016.08.035_b0110","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S1521-6616(03)00210-9","article-title":"The immunological aspects of latency in tuberculosis","volume":"110","author":"Chan","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1016\/j.vaccine.2016.08.035_b0115","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1016\/j.vaccine.2006.12.042","article-title":"The PGRS domain of Mycobacterium tuberculosis PE_PGRS Rv1759c antigen is an efficient subunit vaccine to prevent reactivation in a murine model of chronic tuberculosis","volume":"25","author":"Campuzano","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.035_b0120","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm.2285","article-title":"A multistage tuberculosis vaccine that confers efficient protection before and after exposure","volume":"17","author":"Aagaard","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2016.08.035_b0125","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1501996","article-title":"Bacillus Calmette-Guerin (BCG) revaccination of Adults with latent Mycobacterium tuberculosis infection induces long-lived BCG-reactive NK cell responses","author":"Suliman","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.08.035_b0130","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.smim.2014.09.006","article-title":"BCG-induced protection: effects on innate immune memory","volume":"26","author":"Netea","year":"2014","journal-title":"Semin Immunol"},{"key":"10.1016\/j.vaccine.2016.08.035_b0135","doi-asserted-by":"crossref","first-page":"15443","DOI":"10.1038\/srep15443","article-title":"Genomic expression catalogue of a global collection of BCG vaccine strains show evidence for highly diverged metabolic and cell-wall adaptations","volume":"5","author":"Abdallah","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2016.08.035_b0140","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13238-012-2071-0","article-title":"Binding of bacterial secondary messenger molecule c di-GMP is a STING operation","volume":"4","author":"Shaw","year":"2013","journal-title":"Protein Cell"},{"key":"10.1016\/j.vaccine.2016.08.035_b0145","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1016\/j.vaccine.2010.02.081","article-title":"The potential of 3\u2032,5\u2032-cyclic diguanylic acid (c-di-GMP) as an effective vaccine adjuvant","volume":"28","author":"Chen","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.035_b0150","doi-asserted-by":"crossref","first-page":"11392","DOI":"10.1038\/ncomms11392","article-title":"Thiol reductive stress induces cellulose-anchored biofilm formation in Mycobacterium tuberculosis","volume":"7","author":"Trivedi","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2016.08.035_b0155","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.micpath.2010.07.004","article-title":"Roles of PE_PGRS family in Mycobacterium tuberculosis pathogenesis and novel measures against tuberculosis","volume":"49","author":"Tian","year":"2010","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2016.08.035_b0160","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1586\/14760584.2015.1015995","article-title":"A PE_PGRS33 protein of Mycobacterium tuberculosis: an ideal target for future tuberculosis vaccine design","volume":"14","author":"Gastelum-Avina","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2016.08.035_b0165","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.yexmp.2009.11.008","article-title":"Immunological and proteomic analysis of preparative isoelectric focusing separated culture filtrate antigens of Mycobacterium tuberculosis","volume":"88","author":"Deenadayalan","year":"2010","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.vaccine.2016.08.035_b0170","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1388-1981(01)00116-0","article-title":"Expression, purification, and characterization of the Mycobacterium tuberculosis acyl carrier protein, AcpM","volume":"1532","author":"Schaeffer","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.vaccine.2016.08.035_b0175","doi-asserted-by":"crossref","first-page":"47029","DOI":"10.1074\/jbc.M108903200","article-title":"Purification and biochemical characterization of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthases KasA and KasB","volume":"276","author":"Schaeffer","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2016.08.035_b0180","doi-asserted-by":"crossref","first-page":"e1000081","DOI":"10.1371\/journal.ppat.1000081","article-title":"Mycolic acid modification by the mmaA4 gene of M. tuberculosis modulates IL-12 production","volume":"4","author":"Dao","year":"2008","journal-title":"PLoS Pathog"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16307071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16307071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T12:06:25Z","timestamp":1601035585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16307071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":36,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0264410X16307071"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.035","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The BCG\u0394BCG1419c strain, which produces more pellicle in vitro, improves control of chronic tuberculosis in vivo","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}